MentionFox lists 51 Drug discovery companies. Of them, 42 are Y Combinator companies (the newest batch here is Fall 2026, with 1); 4 filed a Form D notice with the SEC; 5 won an SBIR or STTR award. The median SBIR or STTR award in the table is $1.4M, across 5 awards.
Companies51
Y Combinator42
Form D filers4
SBIR/STTR winners5
Drug discovery startups
| Company | What it does | Date | Amount | Round / stage | Record |
|---|---|---|---|---|---|
| Digital Ether Computing, LLC (funding history) | Filed Sep 23, 2026 | SEC Form D | |||
| Capienda Biotech, LLC | High-throughput kinetic system for small-molecule drug discovery - abstract evidence is accumulating for higher efficacy of small… | Award starts Sep 15, 2026 | $1.4M | SBIR Phase I | Federal award record |
| Halmos Labs | Maximum information per experiment, minimum experiments per conclusion | Fall 2026 | Y Combinator batch | Y Combinator listing | |
| ImmunoVec, Inc. | Filed Jul 14, 2026 | $12.7M | SEC Form D | ||
| Atlas Discovery | AI-native pharma company | Summer 2026 | Y Combinator batch | Y Combinator listing | |
| WonderTx | Extrapolative AI to unlock First-in-Class drugs | Summer 2026 | Y Combinator batch | Y Combinator listing | |
| Natsar Pharmaceuticals, Inc. | Filed May 8, 2026 | $4.2M | SEC Form D | ||
| Certara, Inc. (funding history) | Filed Apr 28, 2026 | $8.6M | SEC Form D | ||
| 10x Science | The AI-native platform for next-generation protein characterization. | Winter 2026 | Y Combinator batch | Y Combinator listing | |
| Rhizome AI | Agent Platform for Life Sciences | Winter 2026 | Y Combinator batch | Y Combinator listing | |
| Microbiotix, Inc. | Novel benzyl-piperidine antifungal agents to treat intractable mucorales infections - title: novel benzyl-piperidine antifungal agents… | Award starts Sep 22, 2025 | $599,327 | STTR Phase I | Federal award record |
| Natsar Pharmaceuticals, Inc. | Drug development of rk-33 for breast cancer treatment - triple-negative breast cancers (tnbcs) are breast cancers that lack expression… | Award starts Sep 22, 2025 | $2.3M | SBIR Phase II | Federal award record |
| Fimbrion Therapeutics Inc | Pyridone compounds as novel antimycobacterial drugs for tuberculosis - project summary/abstract tuberculosis (tb), caused by infection… | Award starts Sep 9, 2025 | $600,000 | SBIR Phase II | Federal award record |
| b12 Labs | Making hard molecules for Pharma and Biotech | Summer 2025 | Y Combinator batch | Y Combinator listing | |
| Stress Therapeutics, Inc. | Investigational new drug (ind)-enabling study for a new therapeutic for alcohol use disorder (aud) - summary | Award starts May 15, 2025 | $2M | SBIR Phase I | Federal award record |
| Ångström AI | Gen AI molecular simulations that reproduce wetlab results | Summer 2024 | Y Combinator batch | Y Combinator listing | |
| Biocartesian | Converting biology into digital molecular maps | Summer 2024 | Y Combinator batch | Y Combinator listing | |
| Evolvere BioSciences | Making Next-Generation Antibiotics that Outpace Bacterial Evolution | Summer 2024 | Y Combinator batch | Y Combinator listing | |
| Eris Biotech | Our drugs engage the immune system to fight tumors | Winter 2024 | Y Combinator batch | Y Combinator listing | |
| ParcelBio | Elevated mRNA for transformative medicines. | Winter 2024 | Y Combinator batch | Y Combinator listing | |
| Tamarind Bio | AI Inference Platform for Drug Discovery | Winter 2024 | Y Combinator batch | Y Combinator listing | |
| Nanograb | Deliver genes to any cell with AI | Summer 2023 | Y Combinator batch | Y Combinator listing | |
| Invitris | Creating new protein-based drugs at scale | Winter 2023 | Y Combinator batch | Y Combinator listing | |
| Novelcare | Empowering every doctor and every patient to participate in research | Winter 2023 | Y Combinator batch | Y Combinator listing | |
| Alixia | Targeting the Tumor Ecosystem to address cancer drug resistance. | Winter 2022 | Y Combinator batch | Y Combinator listing | |
| Cellbyte | AI Agents for Pharma Drug Launches | Winter 2022 | Y Combinator batch | Y Combinator listing | |
| Origami Therapeutics, Inc. | Oral drugs to halt neurodegeneration | Winter 2022 | Y Combinator batch | Y Combinator listing | |
| Rosebud Biosciences | Growing micro-organs to find new drugs | Winter 2022 | Y Combinator batch | Y Combinator listing | |
| Adaptyv | We're building fully automated labs for protein engineering | Summer 2021 | Y Combinator batch | Y Combinator listing | |
| CellChorus | The dynamic single-cell analysis company | Summer 2021 | Y Combinator batch | Y Combinator listing | |
| Harmonic Discovery | Multi-targeted therapeutics to treat complex diseases | Summer 2021 | Y Combinator batch | Y Combinator listing | |
| Parallel Bio | Using the immune system to cure disease | Summer 2021 | Y Combinator batch | Y Combinator listing | |
| Talus Bio | Discovering drugs that target the DNA regulome | Summer 2021 | Y Combinator batch | Y Combinator listing | |
| PipeBio | PipeBio is a SaaS bioinformatics platform to develop antibody drugs. | Winter 2021 | Y Combinator batch | Y Combinator listing | |
| Serna Bio | Genetic Medicine with Small Molecules | Winter 2021 | Y Combinator batch | Y Combinator listing | |
| Valink Therapeutics | Discovering bispecific antibody drug-conjugates (BsADC) against cancer | Winter 2021 | Y Combinator batch | Y Combinator listing | |
| Abalone Bio | We create activating antibodies to treat diseases others can’t. | Winter 2020 | Y Combinator batch | Y Combinator listing | |
| Algen Biotechnologies | Using CRISPR to find treatments for cancer and inflammation | Winter 2020 | Y Combinator batch | Y Combinator listing | |
| Altay Therapeutics | Altay develops disease-modifying therapies targeting transcription… | Winter 2020 | Y Combinator batch | Y Combinator listing | |
| General Proximity | The next generation of induced-proximity medicines. | Winter 2020 | Y Combinator batch | Y Combinator listing | |
| PostEra | Medicinal Chemistry powered by Machine Learning | Winter 2020 | Y Combinator batch | Y Combinator listing | |
| Arpeggio Bio | Arpeggio Bio develops drugs targeting transcription factors using AI… | Summer 2019 | Y Combinator batch | Y Combinator listing | |
| Sequence Bio | Discovering the true signals of disease to power life-changing drugs. | Summer 2019 | Y Combinator batch | Y Combinator listing | |
| Shiru | Shiru leverages ML to create proteins to feed the world sustainably | Summer 2019 | Y Combinator batch | Y Combinator listing | |
| 1910 | Multimodal AI Platform for Modality Agnostic Drug Discovery™ | Winter 2019 | Y Combinator batch | Y Combinator listing | |
| Leah Labs | Living therapies for pets first, and their people next | Winter 2019 | Y Combinator batch | Y Combinator listing | |
| Synkrino Biotherapeutics | Synkrino's AI, SATIS is a powerful, unbiased discovery system for… | Summer 2018 | Y Combinator batch | Y Combinator listing | |
| Macromoltek | Computational antibody design | Winter 2018 | Y Combinator batch | Y Combinator listing | |
| Persephone Biosciences | We are using the gut microbiome to end cancer | Winter 2018 | Y Combinator batch | Y Combinator listing | |
| Verge Genomics | We use human data and AI to develop better drugs faster. | Summer 2015 | Y Combinator batch | Y Combinator listing | |
| Numerion Labs | Artificial intelligence for drug discovery. | Winter 2015 | Y Combinator batch | Y Combinator listing |
Selling to these companies?
Export the list: a spreadsheet of the 51 Drug discovery companies in the table below, with each one's date, amount, round or stage, the record it comes from and its MentionFox page. Free with an account; if you are not signed in, you sign up first and the download starts when you come back to this page.
Export the listA Full Report covers who runs the company, who owns it, where its money comes from and what to watch for, every claim linked to its source. See pricing.
Related startup lists
Biotech (45 shared) AI (24 shared) Healthcare and health tech (2 shared) AI agent (2 shared) Generative AI (1 shared)
Figures come only from the record linked in each row; a blank means the record gives none. How these lists are built.